BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kimura H. EBV in T-/NK-Cell Tumorigenesis. Adv Exp Med Biol 2018;1045:459-75. [PMID: 29896680 DOI: 10.1007/978-981-10-7230-7_21] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kanda T, Yajima M, Ikuta K. Epstein-Barr virus strain variation and cancer. Cancer Sci. 2019;110:1132-1139. [PMID: 30697862 DOI: 10.1111/cas.13954] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
2 Cohen JI, Iwatsuki K, Ko YH, Kimura H, Manoli I, Ohshima K, Pittaluga S, Quintanilla-Martinez L, Jaffe ES. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting. Leuk Lymphoma 2020;61:808-19. [PMID: 31833428 DOI: 10.1080/10428194.2019.1699080] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
3 Sánchez-Romero C, Bologna-Molina R, Paes de Almeida O, Santos-Silva AR, Prado-Ribeiro AC, Brandão TB, Carlos R. Extranodal NK/T cell lymphoma, nasal type: An updated overview. Crit Rev Oncol Hematol 2021;159:103237. [PMID: 33493634 DOI: 10.1016/j.critrevonc.2021.103237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
4 Kim JH, Cho H, Sung H, Jung AR, Lee YS, Lee SW, Ryu JS, Chae EJ, Kim KW, Huh J, Park CS, Yoon DH, Suh C. Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphoma. Sci Rep 2021;11:2880. [PMID: 33536508 DOI: 10.1038/s41598-021-82534-4] [Reference Citation Analysis]
5 Fujiwara S, Nakamura H. Chronic Active Epstein-Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both? Cancers (Basel) 2020;12:E3202. [PMID: 33143184 DOI: 10.3390/cancers12113202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Kimura H, Okuno Y, Sato Y, Watanabe T, Murata T. Deletion of Viral microRNAs in the Oncogenesis of Epstein-Barr Virus-Associated Lymphoma. Front Microbiol 2021;12:667968. [PMID: 34305835 DOI: 10.3389/fmicb.2021.667968] [Reference Citation Analysis]
7 Li F, Freed D, Heidecker G, Galli J, Durr E, Wang D. A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developments. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.04.102] [Reference Citation Analysis]
8 Kimura H, Fujiwara S. Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases. Front Pediatr 2018;6:417. [PMID: 30662890 DOI: 10.3389/fped.2018.00417] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
9 Song YL, Wang BF, Jiang NG, Jin YM, Zeng TT. CD8dimCD3+ lymphocytes in fever patients might be biomarkers of active EBV infection and exclusion indicator of T-LGLL. Biomark Med 2020;14:1703-15. [PMID: 33140976 DOI: 10.2217/bmm-2020-0456] [Reference Citation Analysis]
10 Han L, Sun Y, Lu C, Ma C, Shi J, Sun D. MiR-3614-5p Is a Potential Novel Biomarker for Colorectal Cancer. Front Genet 2021;12:666833. [PMID: 34127929 DOI: 10.3389/fgene.2021.666833] [Reference Citation Analysis]
11 Nakhoul H, Lin Z, Wang X, Roberts C, Dong Y, Flemington E. High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments. mSphere 2019;4:e00248-19. [PMID: 31292228 DOI: 10.1128/mSphere.00248-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Reguraman N, Hassani A, Philip P, Khan G. Uncovering early events in primary Epstein-Barr virus infection using a rabbit model. Sci Rep 2021;11:21220. [PMID: 34707156 DOI: 10.1038/s41598-021-00668-x] [Reference Citation Analysis]
13 Cao Z, Zeng L, Feng L, Feng X. Comprehensive analysis of the differential cellular and EBV miRNA expression profiles in Mature T and NK cell lymphomas. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153846] [Reference Citation Analysis]
14 Kimura H, Okuno Y. [EBV and Lymphomagenesis]. Uirusu 2019;69:13-22. [PMID: 32938890 DOI: 10.2222/jsv.69.13] [Reference Citation Analysis]
15 Sugimoto A. Replication Compartments-The Great Survival Strategy for Epstein-Barr Virus Lytic Replication. Microorganisms 2022;10:896. [PMID: 35630341 DOI: 10.3390/microorganisms10050896] [Reference Citation Analysis]
16 Hara Y, Watanabe T, Yoshida M, Masud HMAA, Kato H, Kondo T, Suzuki R, Kurose S, Uddin MK, Arata M, Miyagi S, Yanagi Y, Sato Y, Kimura H, Murata T, Frappier L. Comprehensive Analyses of Intraviral Epstein-Barr Virus Protein–Protein Interactions Hint Central Role of BLRF2 in the Tegument Network. J Virol. [DOI: 10.1128/jvi.00518-22] [Reference Citation Analysis]
17 Missaoui N, Mestiri S, Bouriga A, Abdessayed N, Belakhdher M, Ghammem M, Abdelkefi M, Mokni M, Hmissa S. Extranodal NK/T-cell lymphoma in Tunisia: clinicopathological features, immunophenotype and EBV infection. J Egypt Natl Canc Inst 2019;31:1. [PMID: 32372136 DOI: 10.1186/s43046-019-0002-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Shafiee A, Shamsi S, Kohandel Gargari O, Beiky M, Allahkarami MM, Miyanaji AB, Aghajanian S, Mozhgani SH. EBV associated T- and NK-cell lymphoproliferative diseases: A comprehensive overview of clinical manifestations and novel therapeutic insights. Rev Med Virol 2022;:e2328. [PMID: 35122349 DOI: 10.1002/rmv.2328] [Reference Citation Analysis]
19 Peng YP, Liu QD, Lin YJ, Peng SL, Wang R, Xu XW, Wei W, Zhong GH, Zhou YL, Zhang YQ, Liu Y, Wang SY, Hong HY, Liu ZG. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma. Radiat Oncol 2021;16:198. [PMID: 34635145 DOI: 10.1186/s13014-021-01898-z] [Reference Citation Analysis]
20 Takahara M, Kumai T, Kishibe K, Nagato T, Harabuchi Y. Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein-Barr Virus Relation. Microorganisms 2021;9:1381. [PMID: 34202088 DOI: 10.3390/microorganisms9071381] [Reference Citation Analysis]
21 Zhao Q, Fan S, Chang Y, Liu X, Li W, Ma Q, Li Y, Wang Y, Zhang L, Zhang M. Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III-IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus. Cancer Manag Res 2019;11:3555-64. [PMID: 31118779 DOI: 10.2147/CMAR.S191929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Knerr JM, Kledal TN, Rosenkilde MM. Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1. Cancers (Basel) 2021;13:4079. [PMID: 34439235 DOI: 10.3390/cancers13164079] [Reference Citation Analysis]
23 Chen S, Wei A, Ma H, Zhang L, Lian H, Zhao Y, Zhang Q, Cheng F, Wang D, Wang T, Li Z, Zhang R. Clinical Features and Prognostic Factors of Children with Chronic Active Epstein-Barr Virus Infection: A Retrospective Analysis of a Single Center. J Pediatr 2021:S0022-3476(21)00674-0. [PMID: 34260897 DOI: 10.1016/j.jpeds.2021.07.009] [Reference Citation Analysis]
24 Kimura H, de Leval L, Cai Q, Kim WS. EBV-associated NK and T-cell lymphoid neoplasms. Curr Opin Oncol 2022. [PMID: 35900729 DOI: 10.1097/CCO.0000000000000889] [Reference Citation Analysis]
25 Yu G, Liu X, Zhou H, An L, Li H, Wu S, Liu Y, Pan X, Qu G, Chu X. Nasal NK/T cell lymphoma mimicking mucosa-associated lymphoid tissue lymphoma in morphology: A case report. Oncol Lett 2019;18:5561-6. [PMID: 31612064 DOI: 10.3892/ol.2019.10865] [Reference Citation Analysis]
26 Kimura H, Kwong YL. EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment. Front Oncol 2019;9:62. [PMID: 30809508 DOI: 10.3389/fonc.2019.00062] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
27 Yu C, Liu W, Zhao M, Xiao H, Wang Y, Luo B. Sequence analysis of Epstein–Barr virus BALF2 gene in associated tumors and healthy individuals from southern and northern China. Future Virology. [DOI: 10.2217/fvl-2021-0177] [Reference Citation Analysis]
28 Saleem A, Natkunam Y. Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis. Int J Mol Sci 2020;21:E1501. [PMID: 32098335 DOI: 10.3390/ijms21041501] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Liu Z, Sarathkumara YD, Chan JKC, Kwong YL, Lam TH, Ip DKM, Chiu BC, Xu J, Su YC, Proietti C, Cooper MM, Yu KJ, Bassig B, Liang R, Hu W, Ji BT, Coghill AE, Pfeiffer RM, Hildesheim A, Rothman N, Doolan DL, Lan Q. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma. Sci Rep 2021;11:23664. [PMID: 34880297 DOI: 10.1038/s41598-021-02788-w] [Reference Citation Analysis]
30 Latour S, Fischer A. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases. Immunol Rev 2019;291:174-89. [PMID: 31402499 DOI: 10.1111/imr.12791] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]